Current Study: A5

Study: A5

Investigator: Thomas Marbury, MD
Research Study: Liver Studies

• The purpose of this research study is to determine whether the study drug is safe and well tolerated when taken by adults with normal and impaired liver function.
• This study is for research purposes only and is not intended to treat your liver disease

Method of Administration:
Daily oral dose of study medication over an 8 day treatment period

To qualify:

• 18 to 80 years old
• Diagnosed with liver disease or liver damage
• May have cirrhosis due to fatty liver disease, including NASH, or history of alcohol-related liver disease
• May have fluid in your abdomen or previous encephalopathy (brain condition that causes irritability, sleepiness, or trouble sleeping)

• Up to 6 weeks total study duration including:
o Up to 4 week screening period
o 10 consecutive days and 9 nights in our research facility

Location: 5055 South Orange Avenue, Orlando, FL 32809

Qualified participants will receive study medication, study related physical exams and laboratory tests

Compensation Qualified study participants will be compensated up to $2,650 for time and travel

Whom to Contact Recruitment Department: 407-240-7876


Orlando Clinical Research Center
5055 South Orange Avenue
Orlando, FL 32809

Recruiting Number: 407.240.7878

Apply now for Study: A5